\nPartnership Supports National Expansion Objectives as Outpatient Demand for Vascular Care Continues to Grow\n<\/p>\n
TAMPA, Fla. & GREENWICH, Conn.–(BUSINESS WIRE)–Amulet Capital Partners, LP (\u201cAmulet\u201d), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that it has acquired United Vein & Vascular Centers (\u201cUVVC\u201d or the \u201cCompany\u201d), a leading provider of high-quality vascular care treatment services. Financial terms of the transaction were not disclosed.\n<\/p>\n
\nEstablished in Florida in 2014, UVVC has grown its footprint nationwide over the last eight years and expanded its platform to provide comprehensive vascular care treatments and services across a range of vein, arterial and persistent wound conditions. The Company\u2019s physicians are board-certified surgeons and vein specialists that are committed to advancing the latest technologies in vascular treatment and providing the highest quality care, while delivering an all-inclusive clinic experience for patients. Today, UVVC operates across more than 30 clinical locations across Florida, Chicago, Colorado and Arizona, with plans to add more locations in both new and existing markets.\n<\/p>\n
\nIn partnering with UVVC, Amulet will support the Company\u2019s long-term growth objectives and the expansion of high-quality treatment capabilities as patient demand for more accessible, office-based treatment settings continues to grow. Amulet will work closely with management to strategically grow the Company\u2019s network of office locations and service mix in both existing and new markets and provide care for more complex lower extremity vascular conditions.\n<\/p>\n
\nUVVC will continue to be led by founder and CEO Dr. Gamal Wazni and the existing management team as the Company builds on its strong track-record of organic growth and commitment to patient outcomes.\n<\/p>\n
\nDr. Wazni commented, \u201cOver the last eight years, we have invested heavily in developing the clinical and operational infrastructure to rapidly scale our platform to support and care for patients in a growing, but underserved, healthcare demographic. As we look to build on our momentum and expand our national footprint, having a deeply experienced, operationally focused partner who shares our vision and commitment to patient care will make all the difference. Amulet is the ideal partner as we look to execute on our strategy and build the leading vascular care platform in the industry.\u201d\n<\/p>\n
\nCarl Zimmerman, Principal at Amulet, commented, \u201cThis investment represents a unique opportunity to partner with the leading management team in the vein and vascular space and deploy our extensive experience partnering with physician practice management companies to support UVVC\u2019s next phase of growth in a dynamic, fragmented market.\u201d\n<\/p>\n
\nJay Rose, Managing Partner at Amulet, added, \u201cAn estimated 100 million Americans suffer from conditions that are treatable by UVVC, and they are increasingly seeking more convenient and comfortable outpatient care options. By strategically expanding its footprint with additional de novo locations and enhancing the unique, all-inclusive vascular care delivery model that UVVC\u2019s physicians provide, Dr. Wazni and the entire team are well positioned for long-term success. We are excited to partner with and support UVVC as they expand vascular care options for patients across the country.\u201d\n<\/p>\n
\nAbout United Vein & Vascular Centers\n<\/p>\n
\nUnited Vein Centers & Vascular Centers operates IAC accredited facilities with office locations serving patients across the nation. The board-certified physicians are vein and vascular experts, supported by thoroughly trained staff, educated in all aspects of vascular health. Through superior clinical practice and by employing the latest in vein and vascular care technologies, UVVC physicians help patients improve their quality of life by relieving symptoms such as pain, aching, and swelling and mitigating downstream exacerbations caused by vascular disease. UVVC\u2019s mission is to keep patients as healthy and active as possible, allowing them to return to their ideal lifestyle.\n<\/p>\n
\nAbout Amulet Capital Partners\n<\/p>\n